7671 - 7680 of 8801 Results
Title
Year
-
OPENTitle: Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson’s diseaseJournal Name: Molecular Therapy - Nucleic AcidsPublisher: Elsevier BVVol: 28Issue #:Start Page: 1End Page: 15Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.omtn.2022.02.007Best OA location URL: https://doi.org/10.1016/j.omtn.2022.02.007Citation Count: 21
-
OPENTitle: The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron lossJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 318Issue #:Start Page: 157End Page: 164Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2019.05.002Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6592621Citation Count: 11
-
RESTRICTEDTitle: Selection of DNA aptamers that prevent the fibrillization of α-synuclein protein in cellular and mouse modelsJournal Name: Molecular Therapy - Nucleic AcidsPublisher: Elsevier BVVol: 35Issue #: 3Start Page: 102251End Page: 102251Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.omtn.2024.102251Best OA location URL: https://doi.org/10.1016/j.omtn.2024.102251Citation Count: 3
-
OPENTitle: Doubly Constrained C-terminal of Roc (COR) Domain-Derived Peptides Inhibit Leucine-Rich Repeat Kinase 2 (LRRK2) DimerizationJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 14Issue #: 11Start Page: 1971End Page: 1980Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.3c00259Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.3c00259Citation Count: 17
- Intramolecular feedback regulation of the LRRK2 Roc G domain by a LRRK2 kinase-dependent mechanism2024OPENTitle: Intramolecular feedback regulation of the LRRK2 Roc G domain by a LRRK2 kinase-dependent mechanismJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.91083.4Best OA location URL: https://doi.org/10.7554/elife.91083.4Citation Count: 0
-
RESTRICTEDTitle: RAB32 Variants in a German Parkinson's Disease CohortJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.30005Citation Count: 3
-
OPENTitle: Nurr1:RXRα heterodimer activation as monotherapy for Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 114Issue #: 15Start Page: 3999End Page: 4004Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1616874114Best OA location URL: https://www.pnas.org/content/pnas/114/15/3999.full.pdfCitation Count: 79
-
RESTRICTEDTitle: Intra-arterial bone marrow mononuclear cells for strokeJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 22Issue #: 2Start Page: 105End Page: 106Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00005-4Citation Count: 1
-
RESTRICTEDTitle: What matters to people with Parkinson’s disease living in Australia?Journal Name: Journal of Clinical NeurosciencePublisher: Elsevier BVVol: 22Issue #: 2Start Page: 338End Page: 341Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jocn.2014.06.097Citation Count: 10
-
OPENTitle: Effect of augmenting cholinergic function on gait and balanceJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-015-0523-xBest OA location URL: https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-015-0523-xCitation Count: 25